BioSec Industry Briefing — Wednesday, October 28, 2026

BioSec Bob here on Wednesday, October 28, 2026 — let’s jump straight in.
Starting with swine respiratory disease: biosecurity, vaccination, and targeted monitoring are forming the backbone of control efforts across the industry, according to Bioengineer.org. Producers managing respiratory challenges are leaning on strict barn protocols, consistent vaccination schedules, and real-time herd monitoring to track disease progression. The combination of these three pillars is proving effective at reducing severity and spread within operations. Respiratory issues remain costly and persistent, making the layered approach critical for maintaining productivity.
Over to disease preparedness on the wild pig front. The Wild Pig Summit, as reported by SteinbechOnline, centered on equipping producers and wildlife managers with tools for disease containment and eradication protocols. Wild pig populations continue to pose biosecurity risks, and the summit brought together operators to share strategies for identifying and controlling feral herds before disease can establish. Victoria County is moving on this directly — crossroadstoday.com is reporting that grant funding is now available to trap damaging feral hogs within the county. Producers and landowners can apply for support to remove problem animals from their operations and surrounding areas.
On the research and prevention side, Pig World is reporting that the University of Sheffield is leading a major research initiative tackling African swine fever globally. The university’s work focuses on understanding ASF transmission and developing stronger defense mechanisms against the virus. Meanwhile, closer to home in Indiana, Brownfield Ag News reports that Indiana Pork has expanded its disease prevention efforts through its Swine Health Advisory Committee, strengthening coordination on biosecurity and monitoring across the state’s operations. Both efforts reflect a strategic push to stay ahead of ASF’s international threat.
Keep your protocols sharp — disease pressure won’t ease up.